The Academy of Pharmaceutical Sciences

Watson Pharmaceuticals provides update on generic Lidoderm application

In response to investment community speculation following release of the transcript of a pre-trial conference call related to its Lidoderm patent challenge, Watson Pharmaceuticals issued the following statement: "Watson's abbreviated new drug application, or ANDA, for a generic version of Lidoderm remains on track.

McKesson Corporation Acquires Proventys' Advanced Decision Support Assets in Oncology

"Proventys is very proud of the innovative offerings we developed to advance cancer care through the use of smart technologies that facilitate more personalized, evidence-based treatment for patients," said Ralph Snyderman, MD, Proventys' founder and chairman.

MSL becomes a key link between pharmaceutical industry and stakeholders

Medical Science Liaisons have become a key link between the pharmaceutical industry and key stakeholders such as thought leaders that drive marketplace success.

Microsoft buys eugenics technology from Merck

Natural News Thursday, February 2, 2012 When you buy Microsoft products, you are now promoting the pharmaceutical industry and its global vaccine agenda.

Gilead Rises on Hepatitis C Trial Results: San Francisco Mover

Gilead Sciences Inc., the drugmaker that acquired Pharmasset Inc. last month for its experimental hepatitis C treatments, gained the most in three years after one of the medicines produced positive clinical trial results.

Cardinal Health says DEA suspends Fla. shipments

Cardinal Health Inc. said Friday that the U.S. Drug Enforcement Administration has suspended its license to sell drugs from a Florida distribution center, and the company plans to fight the action.

FDA approves anxiety drug by Hi-Tech Pharmacal

Roxane's Lorazepam Intensol oral concentrate generated $10 million in branded and generic sales in 2011, according to the firm.

Sustainable Investment

News from Europe's pharmaceutical manufacturing industry coupled with upcoming events, and exclusive articles and interviews from industry experts.

Biz buzz

Hayward-based Impax Laboratories has bought the U.S. rights to AstraZeneca migraine headache drug Zomig, a deal that caused Impax's stock to rocket 7.5 percent higher Thursday.

Manager, Cash Processing Center-Tampa

Tampa, PharMerica Corporation is a premier institutional pharmacy services provider, dedicated to providing quality patient care and innovative pharmacy solutions to institutional customers and patients in long term care settings.

Mylan wins approval for Lipitor generic

Mylan Inc. said Thursday it received tentative approval from the Food and Drug Administration to sell a generic version of heart medicine Lipitor.

Pharma results bolster Cardinal Health 2Q profit

DUBLIN, Ohio - Health care products distributor Cardinal Health Inc.'s fiscal second-quarter profit jumped 22 percent on stronger results from its pharmaceutical business.

The Pharmaceutical Industry Sourcing Landscape In 2011:...

However, over the past few years, with increasing costs for research and development and marketing services, major pharmaceutical companies have turned towards external partners to help them design better drugs, control expenditures, and reduce capital investment.

JPMorgan Chase & Co.

McKesson 's stock had its "overweight" rating reaffirmed by equities research analysts at JPMorgan Chase & Co.

Impax Pharmaceuticals Gains Rights for US Sales of AstraZeneca PLC's...

HAYWARD, Calif.-- -- Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc.

McKesson Corporation Buys Canadian Pharmacy Marketing Group Assets for $918 Million

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia McKesson Corp.

UPDATE 2-Impax Labs licenses Astrazeneca's migraine drug in US

Impax Laboratories said it has licensed AstraZeneca's migraine treatment, Zomig, in the United States and will pay quarterly payments totaling $130 million in 2012 to the British drugmaker.

Achillion, Idenix could miss hep-C merger bonanza

Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn't assume that an eye-popping bid for Idenix Pharmaceuticals and Achillion Pharmaceuticals is just around the corner, according to biotech analysts.

Mylan's Staggering Upside Dwarfs J&J, Endo

For investors concerned about the macroeconomy, biotechnology provides some of the safest plays.

New Strides Against Prostate Cancer

Drug companies have scored a string of recent successes against advanced prostate cancer, ending a long drought during which there seemed to be few weapons to combat the disease.

What is Life is Really Like in Pharma? - These xtranormal Video Cartoons Come Close.

Sadly, the 'xtranormal' video cartoons at the following URL capture all too well what life is like in the pharmaceutical industry - buzzwords, neologisms, nouns turned into verbs, new paradigms, team players - and per the site, endless inane "initiatives" and related threats to sanity.

Teva CEO Change Stokes Best January for Stocks Since '97: Israel Overnight

Teva Pharmaceutical Industries Ltd. is driving the best start of the year for Israeli stocks since 1997 as the drugmaker soothed concerns about new revenue sources by replacing its chief executive officer.

Drug Deals: DLA Awards up to $807M for Pharmaceuticals Delivery

Military meds are big business. In March 2010 the US DLA's Defense Supply Center Philadelphia awarded 2 contracts worth up to $807.1 million to Cardinal Health in Dublin, OH, for drug distribution to US military medical facilities.

7 Radar Movers: RadioShack Gets Whacked 18%, Coinstar Falls 2% and Rent-A-Center Misses Top Line

Shares of McKesson Corp. jumped 3.25 percent after reporting a 94 percent jump in third quarter profits.A The company earned $300 million m compared to $155 million in the previous year's third quarter.

McKesson to buy independent, franchise businesses from pharmacy operator Katz

U.S. health care giant McKesson Corp. is buying a big part of Edmonton-based drug store operator Katz Group Canada Inc.

U.S. giant makes big move on Canadian drug stores

The world's largest health-care services company is making a move into Canada's pharmaceutical retail space, taking control of hundreds of pharmacies across the country.

Biz buzz: McKesson's profit nearly doubles

Santa Clara-based Intel's venture capital unit led a $20 million round of investments in Solera Networks, which provides network security analytics.

Facebook leads industry in display ads

INTERNET Facebook leads in display ads Facebook accounted for 28 percent of online display-advertising impressions in 2011, expanding its lead in the industry, comScore Inc.

Drug firms sign up to new tropical disease fight

Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases.

Wasden obtains $625,000 drug pricing settlement with Mylan

Prescription drug manufacturers Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.

Generic for Watson Pharmaceuticals high blood pressure drug OK'd

Sales of hydrochlorothiazide capsules were about $204 million for the 12 months ending October 2011, according to the pharmaceutical information services and publishing company Wolters Kluwer.

Outlook for pharmaceutical in 2012 stable, says Fitch

Fitch Ratings says that the 2012 outlook for the Indian pharmaceutical industry is stable.

Research-Based Pharmaceutical Industry Pledges 14 Billion Treatments...

Averaging 1.4 billion treatments annually, the donations build upon companies' existing medicines donation programmes which already reach millions of people around the world.

Teva Falls Most in Month on Competition, Recall: Tel Aviv Mover

Teva Pharmaceutical Industries Ltd. declined the most in a month, narrowing the gap with U.S.-traded shares, as a competitor received clearance to sell a generic version of Lovenox and a unit recalled a drug.

Omnicare Sued by FTC to Block Takeover of Rival PharMerica

Omnicare Inc. was sued by the U.S. Federal Trade Commission to block its $440.8 million takeover of rival drug-supply company PharMerica Corp., a deal that regulators said would hurt competition and increase drug prices.

Express Scripts' Lipitor Move Highlights Pressure On Pfizer

Pharmacy-benefit manager Express Scripts Inc. will soon make an adjustment that raises out-of-pocket costs for some customers filling prescriptions of Pfizer Inc.'s cholesterol-lowering drug Lipitor, underscoring the drug maker's challenge of keeping sales high in the face of generic competition.

Zacks Investment Research Analysts Reiterate a "Neutral" Rating on Bristol Myers Squibb

Bristol Myers Squibb 's stock had its "neutral" rating reiterated by Zacks Investment Research in a report issued on Friday.

FTC Sues to Block Omnicare's Bid to Buy Rival Pharmacy Provider PharMerica

The Federal Trade Commission issued a complaint to block Omnicare, Inc.'s hostile acquisition of rival long-term care pharmacy provider PharMerica Corporation, alleging that the combination of the two largest U.S. long-term care pharmacies would harm competition and enable Omnicare to raise the price of drugs for Medicare Part D consumers and ... (more)

Idenix Pharmaceuticals Shares Plunged Temporarily: What You Need to Know

So what: Stifel Nicolaus slapped the dreaded sell rating on Idenix this morning, downgrading it from neutral.

Letter of the Day: Drug dealers

EDITOR: In the midst of the federal crackdown on our medicinal marijuana industry, a British pharmaceutical company is looking for the go-ahead from the Food and Drug Administration to bring in the marijuana drug called Sativex .

Seminar is perfect tonic for Watford's pharmaceutical firmsUpdated...

A lunchtime seminar entitled The Future of Pharma by Professor Brian D Smith was hosted by solicitors Matthew Arnold and Baldwin LLP in conjunction with Watford Chamber of Commerce .

McKesson (MCK) Given "Buy" Rating by Jefferies Group (JEF) Analysts

McKesson 's stock had its "buy" rating reaffirmed by analysts at Jefferies Group in a research report issued to clients and investors on Friday.

How a Memphis Task Force Combats Cargo Theft

After many hours on the road, the long-haul driver pulled his tractor-trailer into a Tennessee truck stop for a break and a hot meal.

Teva Pharmaceutical Industries Ltd (TEVA) Shares Given New $48.00...

Investment analysts at Goldman Sachs raised their price target on shares of Teva Pharmaceutical Industries Ltd to $48.00 in a note issued to investors on Thursday.

Medical Writer Visits Nazareth

The author of Deadly Monopolies talked about the legal, social, and ethical aspects of the role the pharmaceutical industry and others play in the medical world.

Impax Laboratories Schedules Conference Call and Webcast for Fourth Quarter and Full Year 2011 Financial Results

Impax Laboratories, Inc. announced today that its fourth quarter and full year 2011 financial results will be released before the market opens on Tuesday, February 28, 2012 and will be available on Impax's Web site at www.impaxlabs.com . The Company will host a conference call and live webcast with financial analysts at 11:00 a.m., Eastern Time.